Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Low medication adherence is known to contribute to worse health outcomes in the general population.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Dig. Dis. Sci.

Title: Digestive diseases and sciences

Publisher: Springer Nature

ISSN (Electronic): 1573-2568

ISSN (Print): 0163-2116

Publication date (Electronic): February 2017

Volume: 62

Issue: 2

Affiliations

[1 ] Division of Gastroenterology/Hepatology, Department of Medicine, University of California, San Francisco, 513 Parnassus Ave, Med Sci, San Francisco, CA, 94143, USA.

[2 ] Division of Gastroenterology/Hepatology, Department of Medicine, University of California, San Francisco, 513 Parnassus Ave, Med Sci, San Francisco, CA, 94143, USA. Jennifer.lai@ucsf.edu.

Article

Publisher Item ID: 10.1007/s10620-016-4391-z Mid ID: NIHMS835255

DOI: 10.1007/s10620-016-4391-z

PMC ID: 5263169

PubMed ID: 27933471

SO-VID: 0ea7c98a-8d7b-4ba4-8900-6be0787330bb

History

Keywords: End-stage liver disease,Liver transplantation,MMAS-8,Medication adherence,Medication complexity regimen index

Data availability:

Keywords: End-stage liver disease, Liver transplantation, MMAS-8, Medication adherence, Medication complexity regimen index

Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease.

Read this article at

Abstract

Related collections

Stress signalling in stem cells

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 17